Dachaigh › Luchd-obrach › International AIDS Vaccine Initiative (IAVI)
International AIDS Vaccine Initiative (IAVI): Tuarastalan H-1B agus taic bhìosa
Chuir International AIDS Vaccine Initiative (IAVI) 11 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 11. Tuarastal meadhanach a chaidh a thabhann: $163,800.
A bheil International AIDS Vaccine Initiative (IAVI) a’ toirt taic do bhìosaichean H-1B?
Chuir International AIDS Vaccine Initiative (IAVI) 11 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 26 Cèit 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Research Scientist II, Antibody Disc. & B-Cell Resp. Eval. | 2 | $113,916 |
| Medical Director, Early-Stage Clinical Development | 2 | $225,000 |
| Director, Regulatory Affairs | 2 | $166,860 |
| Specialist, Talent Development | 1 | $72,800 |
| PD Associate, HIV Antibody Discovery & Vaccine Responses | 1 | $80,000 |
| Research Scientist II, Antibody Optimization | 1 | $110,000 |
| Associate Director, CMC Recombinant Protein Development | 1 | $163,800 |
| Director, Project Management | 1 | $192,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 1 | $110,000 |
| FY2024 | 4 | $152,500 |
| FY2025 | 5 | $166,860 |
| FY2026 | 1 | $117,832 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
- La Jolla, CA2
- San Diego, CA2
- Skillman, NJ2
- New York, NY1
- Pearland, TX1
- San Benito, TX1
- Rockville, MD1
- Sacramento, CA1
Dreuchdan
- Medical Scientists, Except Epidemiologists5
- Regulatory Affairs Specialists2
- Human Resources Specialists1
- Microbiologists1
- Bioengineers and Biomedical Engineers1
- Natural Sciences Managers1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Research Scientist II, Antibody Disc. & B-Cell Resp. Eval. | $117,832 Ìre II | La Jolla, CA | 26 Cèit 2026 | 5 Iuch 2026 | Dearbhaichte |
| Director, Regulatory Affairs | $166,860 Ìre IV | Skillman, NJ | 2 Sult 2025 | 1 Samh 2025 | Dearbhaichte |
| Director, Regulatory Affairs | $166,860 Ìre IV | Skillman, NJ | 23 Iuch 2025 | 3 Dàmh 2025 | Dearbhaichte |
| Director, Project Management | $192,000 Ìre IV | Sacramento, CA | 27 Ògmh 2025 | 3 Dàmh 2025 | Dearbhaichte |
| Associate Director, CMC Recombinant Protein Development | $163,800 Ìre IV | Rockville, MD | 2 Gibl 2025 | 20 Ògmh 2025 | Dearbhaichte |
| Research Scientist II, Antibody Optimization | $110,000 Ìre II | San Diego, CA | 19 Samh 2024 | 1 Cèit 2025 | Dearbhaichte |
| Medical Director, Early-Stage Clinical Development | $225,000 Ìre IV | Pearland, TX | 23 Iuch 2024 | 9 Sult 2024 | Dearbhaichte |
| Medical Director, Early-Stage Clinical Development | $225,000 Ìre IV | San Benito, TX | 17 Iuch 2024 | 9 Sult 2024 | Dearbhaichte |
| Specialist, Talent Development | $72,800 Ìre II | New York, NY | 8 Gearr 2024 | 13 Cèit 2024 | Dearbhaichte |
| PD Associate, HIV Antibody Discovery & Vaccine Responses | $80,000 Ìre I | San Diego, CA | 8 Faoi 2024 | 4 Màrt 2024 | Dearbhaichte |
| Research Scientist II, Antibody Disc. & B-Cell Resp. Eval. | $110,000 Ìre IV | La Jolla, CA | 3 Cèit 2023 | 5 Iuch 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).